These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32592442)

  • 1. 30-day mortality following palliative radiotherapy.
    Kain M; Bennett H; Yi M; Robinson B; James M
    J Med Imaging Radiat Oncol; 2020 Aug; 64(4):570-579. PubMed ID: 32592442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation of life expectancy prognostic models in patients evaluated for palliative radiotherapy at the end-of-life.
    Mojica-Márquez AE; Rodríguez-López JL; Patel AK; Ling DC; Rajagopalan MS; Beriwal S
    Cancer Med; 2020 Aug; 9(16):5781-5787. PubMed ID: 32592315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting life expectancy in patients with metastatic cancer receiving palliative radiotherapy: the TEACHH model.
    Krishnan MS; Epstein-Peterson Z; Chen YH; Tseng YD; Wright AA; Temel JS; Catalano P; Balboni TA
    Cancer; 2014 Jan; 120(1):134-41. PubMed ID: 24122413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 30 day mortality in adult palliative radiotherapy--A retrospective population based study of 14,972 treatment episodes.
    Spencer K; Morris E; Dugdale E; Newsham A; Sebag-Montefiore D; Turner R; Hall G; Crellin A
    Radiother Oncol; 2015 May; 115(2):264-71. PubMed ID: 25861831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy?
    Sundstrøm S; Bremnes RM; Brunsvig P; Aasebø U; Kaasa S;
    J Thorac Oncol; 2006 Oct; 1(8):816-24. PubMed ID: 17409965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative thoracic radiotherapy near the end of life in lung cancer: A population-based analysis.
    Fraser I; Lefresne S; Regan J; Berthelet E; Chooback N; Ho C; Olson R
    Lung Cancer; 2019 Sep; 135():97-103. PubMed ID: 31447009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of 30-day mortality as a quality metric for palliative radiation treatment: A population-based analysis from Queensland, Australia.
    Guan TL; Kutzko JH; Lunn DP; Dunn NA; Burmeister BH; Dadwal P; Tran N; Holt TR
    J Med Imaging Radiat Oncol; 2024 Apr; 68(3):316-324. PubMed ID: 38500454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Should Palliative Thoracic Radiotherapy Be Fractionated for Octogenarians with Lung Cancer?
    Nieder C; Yobuta R; Mannsåker B; Dalhaug A
    In Vivo; 2018; 32(2):331-336. PubMed ID: 29475917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment as a Quality Indicator in Advanced Lung Cancer.
    Roberts HN; Solomon B; Harden S; Lingaratnam S; Alexander M
    Clin Lung Cancer; 2024 Jul; 25(5):e211-e220.e1. PubMed ID: 38772809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after palliative radiotherapy in geriatric cancer patients.
    Nieder C; Angelo K; Haukland E; Pawinski A
    Anticancer Res; 2014 Nov; 34(11):6641-5. PubMed ID: 25368269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TEACHH model to predict life expectancy in patients presenting for palliative spine radiotherapy: external validation and comparison with alternate models.
    Dosani M; Tyldesley S; Bakos B; Hamm J; Kong T; Lucas S; Wong J; Liu M; Hamilton S
    Support Care Cancer; 2018 Jul; 26(7):2217-2227. PubMed ID: 29392478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative radiotherapy for advanced Cancer: Are we giving it to the right patient at the right time?
    Syadwa AS; Anita ZB
    Med J Malaysia; 2018 Aug; 73(4):190-196. PubMed ID: 30121680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial.
    Falk SJ; Girling DJ; White RJ; Hopwood P; Harvey A; Qian W; Stephens RJ;
    BMJ; 2002 Aug; 325(7362):465. PubMed ID: 12202326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    van den Hout WB; Kramer GW; Noordijk EM; Leer JW
    J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
    Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
    J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Has the pattern of practice in the prescription of radiotherapy for the palliation of thoracic symptoms changed between 1999 and 2006 at the rapid response radiotherapy program?
    Fairchild A; Goh P; Sinclair E; Barnes EA; Ghosh S; Danjoux C; Barbera L; Tsao M; Chow E
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):693-700. PubMed ID: 18262087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative radiotherapy near the end of life.
    Wu SY; Singer L; Boreta L; Garcia MA; Fogh SE; Braunstein SE
    BMC Palliat Care; 2019 Mar; 18(1):29. PubMed ID: 30904024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative Thoracic Radiotherapy for Non-small Cell Lung Cancer: Is There any Impact of Target Volume Size on Survival?
    Nieder C; Imingen KS; Mannsaker B; Yobuta R
    Anticancer Res; 2021 Jan; 41(1):355-358. PubMed ID: 33419831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inoperable non-small cell lung cancer: palliative radiotherapy with two weekly fractions.
    Vyas RK; Suryanarayana U; Dixit S; Singhal S; Bhavsar DC; Neema JP; Baboo HA
    Indian J Chest Dis Allied Sci; 1998; 40(3):171-4. PubMed ID: 9919836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?
    Numico G; Russi E; Merlano M
    Lung Cancer; 2001 Jun; 32(3):213-26. PubMed ID: 11390003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.